These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18581228)

  • 21. Association of psychiatric and substance use disorder comorbidity with cocaine dependence severity and treatment utilization in cocaine-dependent individuals.
    Ford JD; Gelernter J; DeVoe JS; Zhang W; Weiss RD; Brady K; Farrer L; Kranzler HR
    Drug Alcohol Depend; 2009 Jan; 99(1-3):193-203. PubMed ID: 18775607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of retention in dual-focus self-help groups.
    Laudet AB; Magura S; Cleland CM; Vogel HS; Knight EL
    Community Ment Health J; 2003 Aug; 39(4):281-97. PubMed ID: 12908643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How Do Females With PTSD and Substance Abuse View 12-Step Groups? An Empirical Study of Attitudes and Attendance Patterns.
    Najavits LM; de Haan H; Kok T
    Subst Use Misuse; 2015; 50(14):1786-94. PubMed ID: 26606541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. METHODOLOGICAL PLURALISM AND MIXED METHODOLOGY TO STRENGTHEN COMMUNITY PSYCHOLOGY RESEARCH: AN EXAMPLE FROM OXFORD HOUSE.
    May EM; Hunter BA; Jason LA
    J Community Psychol; 2017 Jan; 45(1):100-116. PubMed ID: 28839344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative evaluation of substance abuse treatment IV. The effect of comorbid psychiatric diagnoses on amount of treatment, continuing care, and 1-year outcomes.
    Ouimette PC; Gima K; Moos RH; Finney JW
    Alcohol Clin Exp Res; 1999 Mar; 23(3):552-7. PubMed ID: 10195832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benefits and costs associated with mutual-help community-based recovery homes: The Oxford House model.
    Lo Sasso AT; Byro E; Jason LA; Ferrari JR; Olson B
    Eval Program Plann; 2012 Feb; 35(1):47-53. PubMed ID: 22054524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adherence to medication regimens and participation in dual-focus self-help groups.
    Magura S; Laudet AB; Mahmood D; Rosenblum A; Knight E
    Psychiatr Serv; 2002 Mar; 53(3):310-6. PubMed ID: 11875225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What characterizes substance abusers who commit suicide attempts? Factors related to Axis I disorders and patterns of substance use disorders. A study of treatment-seeking substance abusers in Norway.
    Landheim AS; Bakken K; Vaglum P
    Eur Addict Res; 2006; 12(2):102-8. PubMed ID: 16543746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The 2-year course following detoxification treatment of substance abuse: the possible influence of psychiatric comorbidity.
    Tómasson K; Vaglum P
    Eur Arch Psychiatry Clin Neurosci; 1997; 247(6):320-7. PubMed ID: 9477012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparisons of patients with comorbid psychiatric and substance use disorders: implications for treatment and service delivery.
    Havassy BE; Alvidrez J; Owen KK
    Am J Psychiatry; 2004 Jan; 161(1):139-45. PubMed ID: 14702262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What is a Christian faith-based recovery program?
    Timmons SM
    J Christ Nurs; 2011; 28(3):158-61. PubMed ID: 21853717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of comorbid psychiatric disorders on the outcome of substance abusers: a six year prospective follow-up in two Norwegian counties.
    Landheim AS; Bakken K; Vaglum P
    BMC Psychiatry; 2006 Oct; 6():44. PubMed ID: 17054775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A 12-month prospective follow-up study of patients with schizophrenia-spectrum disorders and substance abuse: changes in psychiatric symptoms and substance use.
    Margolese HC; Carlos Negrete J; Tempier R; Gill K
    Schizophr Res; 2006 Mar; 83(1):65-75. PubMed ID: 16460917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual diagnosis subtypes in urban substance abuse and mental health clinics.
    Hien D; Zimberg S; Weisman S; First M; Ackerman S
    Psychiatr Serv; 1997 Aug; 48(8):1058-63. PubMed ID: 9255839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concurrent and predictive validity of antisocial personality disorder subtyping among substance abusers.
    Cecero JJ; Ball SA; Tennen H; Kranzler HR; Rounsaville BJ
    J Nerv Ment Dis; 1999 Aug; 187(8):478-86. PubMed ID: 10463065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A promising recovery housing model for American Indian communities.
    Jason LA; Kassanits J; Reilly A; Bobak T; Guerrero M; Stevens E; Light JM; Doogan NJ
    J Community Psychol; 2019 Nov; 47(8):1926-1936. PubMed ID: 31475369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comorbid mental health and substance abuse issues among individuals in recovery homes: Prospective environmental mediators.
    Aase DM; Jason LA; Ferrari JR; Li Y; Scott G
    Ment Health Subst Use; 2014 Jan; 7(2):170-183. PubMed ID: 24678342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential relationships between continuity of care practices, engagement in continuing care, and abstinence among subgroups of patients with substance use and psychiatric disorders.
    Schaefer JA; Cronkite RC; Hu KU
    J Stud Alcohol Drugs; 2011 Jul; 72(4):611-21. PubMed ID: 21683043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patients' abstinence status affects the benefits of 12-step self-help group participation on substance use disorder outcomes.
    McKellar JD; Harris AH; Moos RH
    Drug Alcohol Depend; 2009 Jan; 99(1-3):115-22. PubMed ID: 18778901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Life after incarceration: The impact of stability on formerly imprisoned Oxford House residents.
    Abo MG; Salomon-Amend M; Guerrero M; Jason LA
    J Prev Interv Community; 2022; 50(2):191-204. PubMed ID: 34096831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.